Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 08.06.2026 FEUD IE00BF2FL590 340,510.00 EUR 19,423,682.29 57.043  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 08.06.2026 FEUZ IE00B8X9NY41 1,601,594.00 EUR 103,130,163.01 64.392  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 08.06.2026 FEM IE00B8X9NX34 325,002.00 USD 15,818,830.38 48.673  ...

CORAL GABLES, Fla.--(BUSINESS WIRE)--Fresh Del Monte Produce Inc. (NYSE: FDP) today announced that shareholders have approved the change of its corporate name to Del Monte Corporation, marking the next step in the company’s evolution following its previously announced acquisition of select assets of Del Monte Foods Corporation II Inc. and its affiliates. The corporate name change becomes effective today on June 9, 2026. In connection with the name change, the company will also change its New Yo...

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the four‑year follow‑up data from the First-in-Human BIOMAG™-I Clinical Study (NCT04157153)* presented at the EuroPCR conference in Paris, France by Prof. Jan Torzewski (Klinikverbund Allgäu, Germany). Conducted exclusively across European centers and enrolling 116 patients, the study continues to demonstrate a favorable long‑term safety profile1, with no new cardia...

BOSTON & BRISBANE, Australien--(BUSINESS WIRE)--AdvanCell, ein auf klinische Studien spezialisiertes Unternehmen für Radiopharmazeutika, das innovative zielgerichtete Alpha-Therapien gegen Krebs entwickelt, gab heute die Ernennung von Justyna Kelly zur Chief Technology Officer (CTO) und von François Gaudet zum Chief Scientific Officer (CSO) bekannt. Damit wird das Führungsteam des Unternehmens in den USA erweitert, während das Unternehmen seine Kapazitäten in den USA weiter ausbaut und seine wa...

BOSTON et BRISBANE, Australie--(BUSINESS WIRE)--AdvanCell, une entreprise radiopharmaceutique en phase clinique développant des alphathérapies ciblées innovantes contre le cancer, a annoncé aujourd'hui la nomination de Justyna Kelly comme CTO et de François Gaudet comme CSO, renforçant ainsi l'équipe de direction de la société aux États-Unis à mesure qu'elle poursuit le développement de ses capacités aux États-Unis et fait progresser son portefeuille d'alphathérapies ciblées innovantes Justyna...

BOSTON y BRISBANE (Australia)--(BUSINESS WIRE)--AdvanCell, una empresa de radiofármacos en fase clínica que desarrolla innovadoras terapias alfa dirigidas contra el cáncer, anunció hoy el nombramiento de Justyna Kelly como directora de tecnología y François Gaudet como director científico, para ampliar el equipo de liderazgo ejecutivo de la empresa en los Estados Unidos en el contexto del escalado de sus capacidades en los Estados Unidos y el desarrollo de su cartera de innovadoras terapias alf...

SAN FRANCISCO--(BUSINESS WIRE)--Antogen, Inc., an emerging life sciences tools and diagnostics company, today announced the closing of its seed financing round....

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 08.06.2026 FEXD.LN IE00BWTNMB87  457,230.00 USD  45,146,724.94   98.740  ...